高压氧与肿瘤放射治疗

陈洪雷; 彭勇

高压氧与肿瘤放射治疗

陈洪雷 , 彭勇

文章导航 > 国际放射医学核医学杂志 > 2005, 29 > 6: (289-292)

引用本文:

Citation:

高压氧与肿瘤放射治疗

陈洪雷,
彭勇

271000 山东泰安, 解放军第88医院放疗科
中图分类号: R730.58

Hyperbaric oxygenation and radiation therapy

Department of Radiation Oncology, the 88 th Hospital ofPLA, Tai'an City, Shandong 271000, China
CLC number: R730.58

摘要: 高压氧可抑制肿瘤生长和转移,提高肿瘤组织氧合,并诱导肿瘤细胞周期同步化,是一种安全、有效的放射增敏措施,与放疗联合应用可提高疗效。同时,高压氧也是治疗晚期放射性损伤的主要方法之一,但对放射并发症的预防作用尚需进一步研究。
- 高压氧 /
- 肿瘤 /
- 辐射敏感性 /
- 放射性损伤
Abstract: Hyperbaric oxygenation could inhabit the growth and progression of malignant tumor. It could increase the oxygen delivery to tumors and induce cell cycle synchronization of tumor cells. As a safety and effective radiosensitive protocol, it can be used with radiation therapy to enhance the efficacy of clinical treatments. At the same time, hyperbaric oxygenation was also a main treatment of late radiation injuries. But its prophylactic effect on radiation complications requires further studies.
- hyperbaric oxygenation /
- neoplasm /
- radiosensitive /
- radiation injury
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Feldmeier J, Carl U, Hartmann K, et al. Hyperbaric oxygen:does it promote growth or recurrence of malignancy?[J].Undersea Hyperb Med,2003,30(1):1-18.
[2]	Rothfuss A, Merk O, Radermacher P, et al. Evaluation of mutagenic effects of hyperbaric oxygen (HBO) in vitro. Ⅱ. Induction of oxidative DNA damage and mutations in the mouse lymphoma assay[J]. Mutat Res, 2000, 471(1-2):87-94.
[3]	Hartmann KA, van der Kleij AJ, Carl UM, et al. Effects of hyperbaric oxygen and normobaric carbogen on the radiation response of the rat rhabdomyosarcoma R1H[J]. Int J Radiat Oneol Biol Phys, 2001, 51(4):1037-1044.
[4]	Kunugita N, Kohshi K, Kinoshita Y, et al. Radiotherapy after hyperbaric oxygenation improves radioresponse in experimental tumor models[J]. Cancer Lett, 2001, 164(2):149-154.
[5]	Kinoshita Y, Kohshi K, Kunugita N, et al. Preservation of tumour oxygen after hyperbaric oxygenation monitored by magnetic resonance imaging[J]. Br J Cancer, 2000, 82(1):88-92.
[6]	Becker A, Kuhnt T, Liedtke H, et al. Oxygenation measurements in head and neck cancers during hyperbaric oxygenation[J]. Strahlenther Onkol, 2002, 178(2):105-108.
[7]	Kalns JE, Piepmeier EH. Exposure to hyperbaric oxygen induces cell cycle perturbation in prostate cancer cells[J]. In Vitro Cell Dev Biol Anim, 1999, 35(2):98-101.
[8]	Kohshi K, Kinoshita Y, Imada H, et al. Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas[J]. Br J Cancer, 1999,80(1-2):236-241.
[9]	Beppu T, Kamada K, Nakamura R, et al. A phase Ⅱ study of radiotherapy after hyperbaric oxygenation combined with interferon-beta and nimustine hydrochloride to treat supratentorial malignant gliomas[J]. J Neurooncol, 2003, 61(2):161-170.
[10]	Haffty BG, Hurley R, Peters LJ. Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck:results of a randomized clinical trial[J]. Cancer J Sci Am, 1999, 5(6):341-347.
[11]	Haffty BG, Hurley RA, Peters LG. Carcinoma of the larynx treated with hypofractionated radiation and hyperbaric oxygen:long-term tumor control and complications[J]. Int J Radiat Oncol Biol Phys, 1999,45(1):13-20.
[12]	Dische S, Saunders MI, Sealy R, et al. Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy:a report ofa randomised controlled trial[J]. Radiother Oncol, 1999, 53(2):93-98.
[13]	Bui Qc, Lieber M, Withers HR, et al. The efficacy of hyoerbaric oxygen therapy in the treatment of radiation-induced late side effects[J]. Int J Radiat Oncol Biol Phys, 2004, 60(3):871-878.
[14]	Gothard L, Stanton A, MacLaren J, et al. Non-randomised phase Ⅱ trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer[J]. Radiother Oncol, 2004, 70(3):217-224.
[15]	Feldmeier JJ, Heimbach RD, Davolt DA, et al. Hyperbaric oxygen in the treatment of delayed radiation injuries of the extremities[J].Undersea Hyperb Med, 2000, 27(1):15-19.
[16]	Vudiniabola S, Pirone C, Williamson J, et al. Hyperbaric oxygen in the prevention of osteoradionecrosis of the jaws[J]. Aust Dent J, 1999,44(4):243-247.
[17]	Granstrom G, Tjellstrom A, Branemark PI. Osseointegrated implants in irradiated bone:a case-controlled study using adjunctive hyperbaric oxygen therapy[J]. J Oral Maxillofac Surg, 1999, 57(5):493-499.

[1]	王祯祯 , 高光凯 . 高压氧对迟发性放射损伤的作用. 国际放射医学核医学杂志, 2017, 41(1): 63-67. doi: 10.3760/cma.j.issn.1673-4114.2017.01.012
[2]	朱光旭 , 王小华 . 肿瘤辐射敏感性与细胞凋亡. 国际放射医学核医学杂志, 2000, 24(2): 78-82.
[3]	郭万峰 , 丁桂荣 , 韩良辅 . 应用生物标志对肿瘤辐射敏感性的研究. 国际放射医学核医学杂志, 2001, 25(4): 185-188.
[4]	鞠永健 . 放射治疗中肿瘤控制概率的计算方法. 国际放射医学核医学杂志, 2000, 24(3): 138-141.
[5]	刘丽波 , 张海英 . 放射性膀胱炎的治疗和预防. 国际放射医学核医学杂志, 2000, 24(3): 135-137.
[6]	王丽平 , 梁克 . 细胞凋亡与辐射敏感性. 国际放射医学核医学杂志, 2000, 24(2): 75-78.
[7]	杜维霞 . 辐射敏感性影响因素研究. 国际放射医学核医学杂志, 2003, 27(5): 238-240.
[8]	于文儒 , 王继先 . 个体辐射敏感性差异的研究进展及意义. 国际放射医学核医学杂志, 1997, 21(2): 87-90.
[9]	戚瑞祥 , 董娟聪 , 卢良杰 , 张海芹 , 金顺子 . Toll样受体4与肿瘤及其放射敏感性的研究进展. 国际放射医学核医学杂志, 2013, 37(4): 225-229. doi: 10.3760/cma.j.issn.1673-4114.2013.04.009
[10]	李敏 , 孟庆慧 , 胡旭东 , 焦旸 , 徐加英 , 樊赛军 . B细胞易位基因2的表达水平对肿瘤细胞放射敏感性的影响. 国际放射医学核医学杂志, 2013, 37(3): 129-134. doi: 10.3760/cma.j.issn.1673-4114.2013.03.001